Litcius/Paper detail

The Isoforms of Estrogen Receptor Alpha and Beta in Thyroid Cancer

Zhongqin Gong, Shucai Yang, Minghui Wei, Alexander C. Vlantis, Jason Y. K. Chan, C. Andrew van Hasselt, Dongcai Li, Xianhai Zeng, Lingbin Xue, Michael C. F. Tong, George Y. Chen

2022Frontiers in Oncology29 citationsDOIOpen Access PDF

Abstract

The incidence of thyroid cancer was predominant in women, indicating that the sex hormone may have a role in thyroid cancer development. Generally, the sex hormone exerts its function by binding to the correspondent nuclear receptors. Therefore, aberrant of these receptors may be involved in the development of thyroid cancer. Estrogen receptor alpha (ERα) and beta (ERβ), two main estrogen receptors, have been reported to have an important role in the pathogenesis of thyroid cancer. When the ERα and ERβ genes undergo the alternative RNA splicing, some ERα and ERβ isoforms with incomplete functional domains may be formed. To date, several isoforms of ERα and ERβ have been identified. However, their expression and roles in thyroid cancer are far from clear. In this review, we summarized the expressions and roles of ERα and ERβ isoforms in thyroid cancer, aiming to provide the perspective of modulating the alternative RNA splicing of ERα and ERβ against thyroid cancer.

Topics & Concepts

Thyroid hormone receptorEstrogen receptorEstrogen receptor alphaThyroidThyroid cancerEstrogen receptor betaCancer researchGene isoformAlternative splicingCancerThyroid hormone receptor betaNuclear receptorInternal medicineReceptorEndocrinologyRNA splicingHormoneEstrogenMedicineBiologyHormone receptorBreast cancerRNAGeneTranscription factorGeneticsEstrogen and related hormone effectsPI3K/AKT/mTOR signaling in cancerThyroid Cancer Diagnosis and Treatment